KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme Group (CME) EBIT: 2009-2025

Historic EBIT for Cme Group (CME) over the last 17 years, with Sep 2025 value amounting to $972.6 million.

  • Cme Group's EBIT fell 5.04% to $972.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 billion, marking a year-over-year increase of 8.04%. This contributed to the annual value of $3.9 billion for FY2024, which is 14.43% up from last year.
  • As of Q3 2025, Cme Group's EBIT stood at $972.6 million, which was down 13.88% from $1.1 billion recorded in Q2 2025.
  • In the past 5 years, Cme Group's EBIT registered a high of $1.1 billion during Q2 2025, and its lowest value of $613.7 million during Q3 2021.
  • In the last 3 years, Cme Group's EBIT had a median value of $959.6 million in 2024 and averaged $961.6 million.
  • As far as peak fluctuations go, Cme Group's EBIT decreased by 24.46% in 2021, and later increased by 29.16% in 2023.
  • Over the past 5 years, Cme Group's EBIT (Quarterly) stood at $631.7 million in 2021, then increased by 5.79% to $668.3 million in 2022, then increased by 29.16% to $863.2 million in 2023, then grew by 9.72% to $947.1 million in 2024, then dropped by 5.04% to $972.6 million in 2025.
  • Its EBIT was $972.6 million in Q3 2025, compared to $1.1 billion in Q2 2025 and $1.1 billion in Q1 2025.